The FDA Critical Path Initiative and its influence on new drug development

Article Abstract:

The article discusses objectives and success of the Critical Path Initiative that was started by the U.S. Food and Drug Administration (FDA) for modernizing drug development in the country. The organization has started several researches by roping in the public-private partnerships that has led to new developments and lower drug prices.

United States, Science & research, Commodity & service prices, Management dynamics, Research, Management, Evaluation, Prices and rates, Clinical trials, Company business management, United States. Food and Drug Administration, Company pricing policy, Biological markers

---

Magic bullets melt fat

Article Abstract:

Obesity is a disease and not a cosmetic feature, hence research is being conducted to produce effective drugs. This should eventually lead to rational management of the worldwide obesity epidemic.

Manufacturing processes, Care and treatment, Analysis, Obesity, Production processes, Fat metabolism

---

Similar abstracts:

• Abstracts: The deteriorating administrative efficiency of the U.S. health care system. Costs of health care administration in the United States and Canada
• Abstracts: When does 'health eating' suggest an eating disorder? It's time to adopt new strategies for payment success
• Abstracts: Newspaper wins right to publish peer review. Visitation guidelines promote safe, satisfying environments
• Abstracts: Court agrees: Calif. plan shouldn't have fired doctor. Antitrust rules kill network
• Abstracts: Higher lawsuit risks tied to some schools. Medical professor, university face false claims charges

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.